Resources and Tools To Accelerate Oligonucleotide Therapeutics to Market

Oligonucleotide therapeutics are short DNA or RNA molecules that modulate the expression of target RNA for the treatment of diseases. The success of mRNA-based COVID-19 vaccines has brought renewed interest to other nucleic acid drugs, and the oligo therapeutics market is expected to grow by 25–30% in the next five years with over 1,000 oligonucleotide molecules currently in the pipeline.

Download this eBook to learn more about oligonucleotide:

• Trends and insights
• Starting materials
• Profiling and impurity control
• Identification and quantitation